MEDP Key Statistics, Chart & Performance
The current stock price of MEDP is 610.9 USD. In the past month the price increased by 9.66%. In the past year, price increased by 81.09%.
MEDP Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to MEDP. When comparing the yearly performance of all stocks, MEDP is one of the better performing stocks in the market, outperforming 92.17% of all stocks.
MEDP Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to MEDP. Both the health and profitability get an excellent rating, making MEDP a very profitable company, without any liquidiy or solvency issues.
MEDP Financial Highlights
Over the last trailing twelve months MEDP reported a non-GAAP Earnings per Share(EPS) of 14.3. The EPS increased by 25.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 18.36% | ||
| ROA | 24.7% | ||
| ROE | 147.46% | ||
| Debt/Equity | 0 |
MEDP Forecast & Estimates
18 analysts have analysed MEDP and the average price target is 553.98 USD. This implies a price decrease of -9.32% is expected in the next year compared to the current price of 610.9.
For the next year, analysts expect an EPS growth of 19.52% and a revenue growth 19.17% for MEDP
MEDP Ownership
MEDP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 27.62 | 232.46B | ||
| DHR | DANAHER CORP | 30.61 | 166.69B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 188.8 | 57.37B | ||
| IQV | IQVIA HOLDINGS INC | 20.44 | 40.48B | ||
| A | AGILENT TECHNOLOGIES INC | 25.03 | 39.59B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 34.91 | 29.84B | ||
| WAT | WATERS CORP | 30.5 | 23.06B | ||
| ILMN | ILLUMINA INC | 32.49 | 21.64B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 36.75 | 18.69B | ||
| RVTY | REVVITY INC | 23.49 | 12.76B | ||
| TEM | TEMPUS AI INC | N/A | 12.51B | ||
| CRL | CHARLES RIVER LABORATORIES | 20.82 | 10.81B |
Related stock screener links
About MEDP
Company Profile
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company is headquartered in Cincinnati, Ohio and currently employs 6,200 full-time employees. The company went IPO on 2016-08-11. The firm partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The firm also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company’s operations are principally based in North America, Europe, and Asia.
Company Info
MEDPACE HOLDINGS INC
5375 Medpace Way
Cincinnati OHIO 45227 US
CEO: August J. Troendle
Employees: 6200
Phone: 15135799911
MEDPACE HOLDINGS INC / MEDP FAQ
What does MEDP do?
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company is headquartered in Cincinnati, Ohio and currently employs 6,200 full-time employees. The company went IPO on 2016-08-11. The firm partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The firm also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company’s operations are principally based in North America, Europe, and Asia.
Can you provide the latest stock price for MEDPACE HOLDINGS INC?
The current stock price of MEDP is 610.9 USD. The price decreased by -1.16% in the last trading session.
Does MEDP stock pay dividends?
MEDP does not pay a dividend.
What is the ChartMill rating of MEDPACE HOLDINGS INC stock?
MEDP has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What is the Price/Earnings (PE) ratio of MEDPACE HOLDINGS INC (MEDP)?
The PE ratio for MEDPACE HOLDINGS INC (MEDP) is 42.72. This is based on the reported non-GAAP earnings per share of 14.3 and the current share price of 610.9 USD.
What is the employee count for MEDP stock?
MEDPACE HOLDINGS INC (MEDP) currently has 6200 employees.
Can you provide the ownership details for MEDP stock?
You can find the ownership structure of MEDPACE HOLDINGS INC (MEDP) on the Ownership tab.